The Effectiveness of Kinesiologic Taping in Patients With Knee Rheumatoid Arthritis
NCT ID: NCT07253766
Last Updated: 2025-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2024-11-01
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aim to answer:
* Is kinesiologic taping applied to the knee joint an effective treatment for pain, mobility, and kinesiophobia in individuals diagnosed with rheumatoid arthritis?
* Which is more effective? Kinesiologic taping or non-therapeutic sham taping? Which is better for pain, functional capacity, kinesiophobia and disease activity? Researchers will compare kinesiologic taping and non-therapeutic sham taping . Patients will be randomly divided into groups. The first group of patients was treated with sham taping, and the application period was applied consecutively for 4 weeks, with a minimum interval of 3 days and a maximum interval of 5 days. Group 2 patients underwent kinesiological taping, with the application period ranging from 3 to 5 days per week for 4 consecutive weeks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Kinesio Taping and Sham Taping in Knee Osteoarthritis
NCT05320562
The Effect of Physical Therapy Modalities and Kinesio Taping in Patients With Knee Osteoarthritis
NCT05211544
The Efficacy of Kinesiotaping on Pain, Edema and Functionality After Total Knee Arthroplasty
NCT05457686
The Instant Effect of Kinesiology Taping in Patients With Knee OA
NCT05160246
Kinesiotaping in Knee Osteoarthritis
NCT05351996
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
kinesiologic taping group
Kinesiology tape will be applied to the knee joint.
kinesiologic taping
The taping will be applied to the knee joint for 4 weeks.
Sham taping
Non-therapeutic sham taping will be applied to the knee joint
sham taping
The non-therapeutic taping will be applied to the knee joint for 4 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
kinesiologic taping
The taping will be applied to the knee joint for 4 weeks.
sham taping
The non-therapeutic taping will be applied to the knee joint for 4 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with acute or chronic rheumatoid arthritis;
* Patients whose rheumatic medication protocol has not changed in the last 3 months; -Patients who do not smoke, drink alcohol or use drugs;
* Patients who have no vision, hearing or speech problems;
* Patients who are not amputees;
* Patients who can walk independently.
Exclusion Criteria
* individuals with neurological disorders, severe chronic obstructive pulmonary disease, liver or kidney failure, malignancies, uncontrolled diabetes mellitus, major psychiatric disorders, or pregnancy; and those with concomitant conditions that could cause balance problems.
* Pregnant and breastfeeding women;
* individuals who had undergone surgery in the last few months;
* patients with loss of cooperation (e.g., those diagnosed with dementia or Alzheimer's disease) were also excluded from the study.
45 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Rumeli University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ozden Baskan
Assist.Prof
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Rumeli University
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Istanbul Rumeli University
Identifier Type: OTHER
Identifier Source: secondary_id
E53938333-050-45035
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.